ArticleNPJ precision oncology2026
KRAS and BRAF mutations modify adjuvant chemotherapy outcomes in early stage colorectal cancer.
Durgesh Wankhede et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it